OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
Jane E. Remillard is the leader of the Life Sciences Intellectual Property Team at Nelson Mullins, firstname.lastname@example.org
August 13, 2020
Stringent patentability requirements present a challenge to obtaining broad-based antibody claims, so companies should develop a strategy based on multiple reinforcing layers of protection.